Bellevue Group’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $28.7M | Sell |
|
|||||
|
2024
Q2 | $33.4M | Sell |
|
|||||
|
2024
Q1 | $42.3M | Sell |
|
|||||
|
2023
Q4 | $56.4M | Buy |
|
|||||
|
2023
Q3 | $40.8M | Sell |
|
|||||
|
2023
Q2 | $50.5M | Sell |
|
|||||
|
2023
Q1 | $40.7M | Sell |
|
|||||
|
2022
Q4 | $37.1M | Sell |
|
|||||
|
2022
Q3 | $60.7M | Buy |
|
|||||
|
2022
Q2 | $56M | Sell |
|
|||||
|
2022
Q1 | $58.2M | Sell |
|
|||||
|
2021
Q4 | $73.9M | Hold |
|
|||||
|
2021
Q3 | $109M | Buy |
|
|||||
|
2021
Q2 | $157M | Sell |
|
|||||
|
2021
Q1 | $119M | Buy |
|
|||||
|
2020
Q4 | $139M | Sell |
|
|||||
|
2020
Q3 | $79.4M | Buy |
|
|||||
|
2020
Q2 | $58.8M | Hold |
|
|||||
|
2020
Q1 | $33.9M | Buy |
|
|||||
|
2019
Q4 | $44.5M | Sell |
|
|||||
|
2019
Q3 | $34.3M | Buy |
|
|||||
|
2019
Q2 | $38.2M | Buy |
|